Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

Conditions: Systemic Lupus Erythematosus Interventions: Biological: MK-6194; Biological: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting

Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials